Pharmacokinetic of Thoracic Paravertebral Ropivacaine
Status:
Active, not recruiting
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
The study aims to investigate the pharmacokinetic of ropivacaine in patients undergoing
ultrasound guided thoracic paravertebral block (TPVB) both after a single-bolus injection via
the thoracic paravertebral catheter given before the start of surgery and after continuous
thoracic paravertebral infusion that will start after the end of the procedure in order to
achieve postoperative analgesia after open thoracotomy during the first 3 postoperative days